Exencial Wealth Advisors LLC Purchases 98 Shares of Cardinal Health, Inc. (NYSE:CAH)

Exencial Wealth Advisors LLC lifted its position in Cardinal Health, Inc. (NYSE:CAH) by 1.8% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 5,558 shares of the company’s stock after buying an additional 98 shares during the period. Exencial Wealth Advisors LLC’s holdings in Cardinal Health were worth $657,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in CAH. Van ECK Associates Corp lifted its stake in shares of Cardinal Health by 4.9% in the third quarter. Van ECK Associates Corp now owns 31,996 shares of the company’s stock worth $3,581,000 after buying an additional 1,507 shares in the last quarter. QRG Capital Management Inc. lifted its stake in shares of Cardinal Health by 83.3% in the third quarter. QRG Capital Management Inc. now owns 30,135 shares of the company’s stock worth $3,331,000 after buying an additional 13,697 shares in the last quarter. NorthRock Partners LLC bought a new position in shares of Cardinal Health in the third quarter worth approximately $537,000. HF Advisory Group LLC lifted its stake in shares of Cardinal Health by 8.4% in the third quarter. HF Advisory Group LLC now owns 8,597 shares of the company’s stock worth $950,000 after buying an additional 663 shares in the last quarter. Finally, Avidian Wealth Enterprises LLC lifted its position in Cardinal Health by 4.6% during the third quarter. Avidian Wealth Enterprises LLC now owns 6,114 shares of the company’s stock valued at $676,000 after purchasing an additional 269 shares during the period. Institutional investors own 87.17% of the company’s stock.

Cardinal Health Trading Up 0.9 %

Cardinal Health stock opened at $127.50 on Thursday. The firm has a 50-day moving average price of $125.28 and a 200-day moving average price of $118.57. The firm has a market capitalization of $30.80 billion, a PE ratio of 23.79, a price-to-earnings-growth ratio of 1.49 and a beta of 0.63. Cardinal Health, Inc. has a 12-month low of $93.17 and a 12-month high of $132.84.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, January 30th. The company reported $1.93 EPS for the quarter, beating analysts’ consensus estimates of $1.74 by $0.19. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. As a group, sell-side analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, April 15th. Investors of record on Tuesday, April 1st will be paid a $0.5056 dividend. This represents a $2.02 dividend on an annualized basis and a yield of 1.59%. The ex-dividend date is Tuesday, April 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 37.69%.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on CAH. TD Cowen upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating and increased their price objective for the company from $130.00 to $144.00 in a research report on Wednesday, January 8th. Citigroup increased their price objective on shares of Cardinal Health from $120.00 to $129.00 and gave the company a “neutral” rating in a research report on Friday, January 10th. Wells Fargo & Company increased their price objective on shares of Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 4th. Evercore ISI upgraded shares of Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price objective on the stock in a research report on Tuesday, January 7th. Finally, Jefferies Financial Group upgraded shares of Cardinal Health from a “hold” rating to a “buy” rating and increased their price objective for the company from $140.00 to $150.00 in a research report on Wednesday, February 5th. Four equities research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. Based on data from MarketBeat.com, Cardinal Health has an average rating of “Moderate Buy” and a consensus target price of $139.36.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.